Introduction: Traumatic brain injury (TBI) is a major worldwide neurological disorder of
epidemic proportions. To date, there are still no FDA-approved therapies to treat any forms …

Research into TBI biomarkers has accelerated rapidly in the past decade owing to the
heterogeneous nature of TBI pathologies and management, which pose challenges to TBI …

Background In order to improve injury assessment of brain injuries, protein markers of
pathophysiological processes and tissue fate have been introduced in the clinic. The most …

Mild traumatic brain injury (mTBI), also referred to as concussion, remains a controversial
diagnosis because the brain often appears quite normal on conventional computed …

Military psychiatry, a new subcategory of psychiatry, has become an invaluable, intangible
effect of the war. In this review, we begin by examining related military research …

BACKGROUND: This study compared early serum levels of ubiquitin C-terminal hydrolase
(UCH-L1) from patients with mild and moderate traumatic brain injury (TBI) with uninjured …

Diffuse axonal injury (DAI) remains a prominent feature of human traumatic brain injury (TBI)
and a major player in its subsequent morbidity. The importance of this widespread axonal …

The role of systemic autoimmunity in human traumatic brain injury (TBI) and other forms of
brain injuries is recognized but not well understood. In this study, a systematic investigation …

BACKGROUND: Brain damage markers released in cerebrospinal fluid (CSF) and blood
may provide valuable information about diagnosis and outcome prediction after traumatic …

Ubiquitin C-terminal hydrolase-L1 (UCH-L1) is a neuron-specific enzyme that has been
identified as a potential biomarker of traumatic brain injury (TBI). The study objectives were …